Syrian hamsters become anemic and exhibit delayed growth following oral infection with third-stage Ancylostoma ceylanicum hookworm larvae. Here we describe experiments designed to determine the feasibility of adult worm transfer (AWT) between hosts, a technique that would facilitate the specific study of bloodfeeding hookworms in vivo without prior exposure of the host to larva-specific antigens, permit the ex vivo manipulation of adult parasites prior to reimplantation, and also allow for cross-species transfer of worms. Weanling hamsters given an oral AWT of 40 or 60 mixed-sex A. ceylanicum worms rapidly developed anemia; in the higher-dose group, hemoglobin levels declined from prechallenge levels by 44% within 4 days following AWT. Long-term survival of transferred worms was demonstrated by recovery of parasites from the intestines 42 days after AWT. AWT hamsters acquired humoral immune responses against soluble adult hookworm extracts and excretory-secretory products that were comparable in magnitude to those of animals given a typical infection with larvae. In AWT experiments employing the nonpermissive murine model, C57BL/6 mice given adult worms rapidly became anemic and lost weight in a manner similar to AWT hamsters. Infection of additional mouse strains demonstrated that while C57BL/10 and CD-1 mice also developed anemia following AWT, BALB/c mice were resistant. The technique of AWT to mice may further our understanding of hookworm pathogenesis by allowing the study of adult hookworm infections in a species with well-characterized genetics and an abundance of available reagents.Hundreds of millions of persons worldwide suffer from disease caused by bloodfeeding hookworms (12, 13), with children and pregnant women bearing a particularly heavy pathological burden (14,(34)(35)(36)(37)40). Effective anthelmintic agents for hookworm are available (1); however, reinfection typically occurs quickly following treatment (2, 28), and drug resistance has been documented in human isolates (16,33). Accordingly, novel strategies to control hookworm disease, such as vaccines, may offer a welcome addition to currently available treatment and control options.Over the past 30 years, the Syrian golden hamster (Mesocricetus auratus) has been utilized as a rodent model for studies of hookworm pathology, immunology, and vaccination. Unlike mice, which do not generally permit the development of adult Ancylostoma sp. hookworms upon larval infection (9, 30), immunocompetent hamsters are fully permissive hosts for the human hookworm Ancylostoma ceylanicum (29,31,38). Our group (5) and others (17, 25) have found that, when infected with A. ceylanicum larvae, hamsters exhibit the major clinical features observed in children, namely, anemia and delayed growth. It has been demonstrated that immunization with soluble extracts or secretory products from adult A. ceylanicum worms leads to reduced worm burdens (20) or reduced pathology (5) in hamsters following challenge infection, establishing the utility of this model for vaccine d...